These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1394151)

  • 21. Risk of lymphoma in inflammatory bowel disease.
    Loftus EV; Tremaine WJ; Habermann TM; Harmsen WS; Zinsmeister AR; Sandborn WJ
    Am J Gastroenterol; 2000 Sep; 95(9):2308-12. PubMed ID: 11007233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intakes of fruits, vegetables, and related nutrients and the risk of non-Hodgkin's lymphoma among women.
    Zhang SM; Hunter DJ; Rosner BA; Giovannucci EL; Colditz GA; Speizer FE; Willett WC
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):477-85. PubMed ID: 10815692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.
    Olson JE; Janney CA; Rao RD; Cerhan JR; Kurtin PJ; Schiff D; Kaplan RS; O'Neill BP
    Cancer; 2002 Oct; 95(7):1504-10. PubMed ID: 12237919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Primary cerebral non-Hodgkin's lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the registry of non-Hodgkin's lymphoma in western Denmark, LYFO and the cancer registry, Kraeftens Bekaempelse].
    Jensen MK; d'Amore FA; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Ugeskr Laeger; 1996 Jul; 158(31):4406-12. PubMed ID: 8759999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Gobbi PG; Angrilli F; Brugiatelli M; Musto P; Federico M
    Haematologica; 2008 Sep; 93(9):1335-42. PubMed ID: 18698083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non Burkitt's non-Hodgkin's lymphoma in Ile-Ife.
    Adelusola KA; Durosinmi MA
    Niger Postgrad Med J; 2004 Dec; 11(4):290-3. PubMed ID: 15627159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing patterns in breast cancer incidence trends.
    Holford TR; Cronin KA; Mariotto AB; Feuer EJ
    J Natl Cancer Inst Monogr; 2006; (36):19-25. PubMed ID: 17032890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent trends in the incidence of lymphomas in Kuwait.
    al-Bahar S; Pandita R; al-Bahar E; al-Muhana A; al-Yaseen N
    Neoplasma; 1996; 43(4):253-7. PubMed ID: 8931750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An epidemic of non-Hodgkin's lymphoma: comments on time trends, possible etiologies, and the role of pathology.
    Weisenburger DD
    Mod Pathol; 1992 Sep; 5(5):481-2. PubMed ID: 1344808
    [No Abstract]   [Full Text] [Related]  

  • 31. Secular trends in incidence and mortality of non-Hodgkin's lymphoma in China, 1990-2019, and predictions to 2030: Outlook for the future burden of disease.
    Su H; Xie S; Lyu J; Liu Y; Zhang Y
    Tumori; 2024 Oct; 110(5):348-354. PubMed ID: 39096014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in the descriptive epidemiology of non-Hodgkin's lymphoma in Great Britain?
    Cartwright RA
    Cancer Res; 1992 Oct; 52(19 Suppl):5441s-5442s. PubMed ID: 1394150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of three methods of analysis for age-period-cohort models with application to incidence data on non-Hodgkin's lymphoma.
    McNally RJ; Alexander FE; Staines A; Cartwright RA
    Int J Epidemiol; 1997 Feb; 26(1):32-46. PubMed ID: 9126501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time trends in the incidence of renal carcinoma: analysis of Connecticut Tumor Registry data, 1935-1989.
    Katz DL; Zheng T; Holford TR; Flannery J
    Int J Cancer; 1994 Jul; 58(1):57-63. PubMed ID: 8014016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating age, period and cohort effects using the multistage model for cancer.
    Holford TR; Zhang Z; McKay LA
    Stat Med; 1994 Jan; 13(1):23-41. PubMed ID: 9061838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysing the temporal effects of age, period and cohort.
    Holford TR
    Stat Methods Med Res; 1992; 1(3):317-37. PubMed ID: 1341663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Trend analysis in Hodgkin disease mortality in the German Federal Republic 1955-1989: a comparison of log-linear models with descriptive standard methods].
    Heuer C; Blettner M
    Soz Praventivmed; 1994; 39(4):217-26. PubMed ID: 7941772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review and meta-analysis of glyphosate exposure and risk of lymphohematopoietic cancers.
    Chang ET; Delzell E
    J Environ Sci Health B; 2016; 51(6):402-34. PubMed ID: 27015139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chapter 13: CISNET lung models: comparison of model assumptions and model structures.
    McMahon PM; Hazelton WD; Kimmel M; Clarke LD
    Risk Anal; 2012 Jul; 32 Suppl 1(Suppl 1):S166-78. PubMed ID: 22882887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma.
    Kilfoy BA; Zheng T; Lan Q; Han X; Holford T; Hein DW; Qin Q; Leaderer B; Morton LM; Yeager M; Boyle P; Zhao P; Chanock S; Rothman N; Zhang Y
    Cancer Causes Control; 2010 Jan; 21(1):127-33. PubMed ID: 19809881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.